Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 13/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20133653 | 0.90 | P2RY12 (0.37) | P2RY12CYP2C9CYP3A4CHRM2DRD3 | |
| SCHEMBL20129671 | 0.86 | ALDH1A1 (0.42) | P2RY12CYP2C9CYP3A4CHRM2DRD3 | |
| SCHEMBL20129672 | 0.76 | MTOR (0.42) | CYP2C9CYP3A4DRD3ALDH1A1KDM4E | |
| SCHEMBL20129664 | 0.76 | ALDH1A1 (0.39) | P2RY12CYP2C9CYP3A4CHRM2DRD3 | |
| SCHEMBL22693207 | 0.74 | L3MBTL1 (0.33) | P2RY12MAPTALDH1A1KDM4EL3MBTL1 | |
| SCHEMBL20129663 | 0.72 | MTOR (0.42) | CYP2C9CYP3A4DRD3ALDH1A1KDM4E | |
| SCHEMBL20129630 | 0.72 | MTOR (0.42) | P2RY12CYP2C9CYP3A4DRD3ALDH1A1 | |
| SCHEMBL20129635 | 0.72 | MTOR (0.41) | CYP2C9CYP3A4DRD3MAPTALDH1A1 | |
| SCHEMBL20129670 | 0.71 | MTOR (0.41) | CYP2C9CYP3A4DRD3ALDH1A1KDM4E | |
| SCHEMBL20133848 | 0.70 | KDM4E (0.37) | CYP2C9MAPTALDH1A1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10844013-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | NAVITOR PHARMACEUTICALS, INC. (US) | 2020-11-24 | — | — | US | disclosed |
| US-10414727-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | NAVITOR PHARMACEUTICALS, INC. (US) | 2019-09-17 | — | — | US | disclosed |
| US-20180127370-A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | NAVITOR PHARMACEUTICALS, INC. | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10844013-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | MTOR, RICTOR, RPTOR | P2RY12 1391/4885CYP2C9 4040/4885CYP3A4 3827/4885 |
| US-10414727-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | MTOR, RICTOR, RPTOR | P2RY12 1391/4885CYP2C9 4040/4885CYP3A4 3827/4885 |
| US-20180127370-A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | MTOR, RICTOR, RPTOR | P2RY12 1391/4885CYP2C9 4040/4885CYP3A4 3827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.